18 Members•4,119 Posts

Pharma & Biotech

Custom Health quarterly revenue rises thanks to InnovativeRx deal

Jul 3, 2026

Angela Harmantas

Custom Health targets U.S. growth with connected pharmacy platform and TSX debut

Jul 2, 2026

Steve Darling

Imugene CEO details azer-cel trial milestone - ICYMI

Jul 2, 2026

Jonathan Jackson

Imugene CEO on Phase 1b azer-cel data: second complete response

Jul 2, 2026

Kerry Stevenson

Imugene reports second complete response in azer-cel BTKi cohort

Jul 1, 2026

Jonathan Jackson

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

Jul 1, 2026

Jonathan Jackson

EMV Capital to deconsolidate Glycotest and ProAxsis after fundraisings

Jul 1, 2026

Ian Lyall

Abivax shares jump as updated trial data eases safety concerns

Jun 30, 2026

Emily Jarvie

Imugene reports first complete response in azer-cel BTKi cohort

Jun 30, 2026

Jonathan Jackson

Merck, AbbVie probed by US lawmakers over China clinical trials: report

Jun 30, 2026

Emily Jarvie

Peak Processing expands into US THC beverage market with Fryday Kush deal

Jun 30, 2026

Jonathan Jackson

Orthocell expands Remplir humanitarian program in Ukraine after battlefield trauma use

Jun 30, 2026

Ephrem Joseph

Poolbeg Pharma secures South African patent for lead drug candidate - UPDATE

Jun 30, 2026

Ian Lyall

Futura Medical reports 'highly positive' data for female sexual health treatment

Jun 30, 2026

Ian Lyall

Imugene azer-cel trial shows complete response

Jun 30, 2026

Jonathan Jackson

Lumos Diagnostics receives A$710,000 R&D tax rebate to support point-of-care technology development

Jun 29, 2026

Jonathan Jackson

Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up

Jun 29, 2026

Ian Lyall

genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal

Jun 29, 2026

Ian Lyall

Thalia Therapeutics goes clinical-stage overnight with Sanmirna acquisition

Jun 29, 2026

Stephen Gunnion

Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE

Jun 29, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy